Additionally, the CA-inhibited invasiveness of GBM cells is attributed to the upregulation of CHIP and subsequent down-regulation of AXL by ubiquitin-mediated proteasome degradation, downregulation of GAS6 and subsequent inhibition of the JAK2/MEK/ERK axis. The gene discussed is AXL; the disease is glioblastoma.